Filing Details

Accession Number:
0001618835-19-000214
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-04 17:34:05
Reporting Period:
2019-12-02
Accepted Time:
2019-12-04 17:34:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618835 Evofem Biosciences Inc. EVFM Pharmaceutical Preparations (2834) 208527075
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726183 Kelly Culwell C/O Evofem Biosciences, Inc.
12400 High Bluff Drive, Suite 600
San Diego CA 92130
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-02 1,000 $7.35 43,538 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.